ClinicalTrials.gg
RecruitingNCT07656389Updated Nov 13, 2026

An AI-Based Prediction of Cognitive Capacity in Older Adults and Individuals With Mild Cognitive Impairment During Virtual Reality Driving Tasks

An observational study in Mild Cognitive Impairment (MCI), Virtual Reality and Eye Movement Disorder, sponsored by National Cheng-Kung University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 30 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by National Cheng-Kung University Hospital · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 13, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
192
Ages
30 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 111 studies in Cognitive Dysfunction with a site in Taiwan — 24 open to participants now, 29 under way, 3 of them phase 3. Cognitive Dysfunction · Taiwan.

Planned enrollment
8th of 17
192 · median 192
Started
2026
with 4 others
Observational
17 of 111
6 open now
Primary completion
2029-12
later than 25 of 28 live
Registered
108th of 111
by date
Lead sponsor
3 of 111
National Cheng-Kung University Hospital

Among the 111 studies in Cognitive Dysfunction with a site in Taiwan, this one is the 8th largest by planned enrollment of the 17 observational ones that give a count, is one of 5 that started in 2026, is one of 17 observational ones, reaches primary completion later than 25 of the 28 other live ones, and was the 108th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

24 of the 111 studies in Cognitive Dysfunction with a site in Taiwan are open now. Recruiting first, the newest first:

18 more — sign in →

All 24 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 30 Years to 85 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 111 studies in Cognitive Dysfunction with a site in Taiwan, or all of them as a file.
02

Study summary

Driving ability in older adults is essential for independent mobility and social participation, yet declines under high cognitive load or distraction often lead to visual attention failures such as "look-but-fail-to-see," increasing crash risk. Older adults and individuals with mild cognitive impairment (MCI) show impairments in visual attention, executive control, and visuomotor integration, which are not adequately captured by conventional assessments. Virtual reality (VR) integrated with eye-tracking and upper-limb motion analysis enables ecologically valid simulation of driving scenarios and precise quantification of visuomotor behavior. However, current studies are limited by single-scenario designs, unimodal AI models, and insufficient integration of action-related data.

This study proposes a multi-phase framework: Year 1 develops an eye-movement-based AI model for MCI identification; Year 2 integrates multimodal data in VR driving tasks; and Year 3 establishes an explainable AI system with longitudinal validation. The study aims to advance cognitive assessment and develop a digital tool for early MCI detection and driving risk prediction.

Read the detailed description

Driving ability in older adults is closely associated with independent mobility and social participation. However, under conditions of high cognitive load or distraction, visual attention failures-such as the "look-but-fail-to-see" phenomenon-frequently occur and substantially increase crash risk. Previous studies have demonstrated that older adults and individuals with mild cognitive impairment (MCI) exhibit declines in visual attention allocation, executive control, and visuomotor transformation efficiency. These dynamic regulatory processes are difficult to capture using conventional paper-and-pencil or static neuropsychological assessments, underscoring the need for ecologically valid and dynamic evaluation approaches.

Virtual reality (VR), when integrated with eye-tracking and upper-limb motion analysis, enables the simulation of realistic driving environments under safe and controlled conditions. This approach facilitates precise quantification of visual search behavior, hazard detection, and visuomotor coupling, thereby offering a novel framework for cognitive assessment and driving risk prediction. Despite these advances, three critical gaps remain in the current literature: (1) a lack of systematic investigations focusing on older adults and individuals with MCI across diverse VR driving scenarios to examine visual search and attentional control; (2) artificial intelligence (AI) models that are predominantly limited to single tasks or single modalities, restricting their ability to generalize across contexts; and (3) insufficient integration of upper-limb operational data to fully characterize the dynamic interactions among vision, action, and cognition.

To address these gaps, this study adopts a multi-phase, multi-level research design. In Year 1, a VR-based eye-movement system incorporating controllable cognitive load will be developed to examine pro-saccade and anti-saccade performance among young adults, cognitively healthy older adults, and individuals with MCI. This phase will establish a high-sensitivity, eye-movement-based AI model for MCI identification. In Year 2, the framework will be extended to multi-scenario VR driving tasks through the synchronous integration of eye-tracking and upper-limb operational data, enabling characterization of visuomotor coupling under varying cognitive demands. External validation, transfer learning, and multimodal fusion techniques will be applied to enhance cross-scenario generalizability. In Year 3, multimodal datasets will be integrated to develop an explainable artificial intelligence (XAI) prediction system. Longitudinal follow-up will be conducted to evaluate its prognostic validity for changes in cognitive and driving performance, ultimately leading to a clinically applicable decision-support prototype.

At the theoretical level, this study aims to elucidate the mechanisms underlying visual attention, working memory, executive control, and visuomotor coupling in older adults and individuals with MCI under dynamic conditions. At the clinical and practical levels, it seeks to develop a non-invasive and repeatable digital cognitive screening tool for early MCI detection and older-driver risk assessment, as well as to provide evidence-based support for traffic safety policy development.

03

Conditions studied

  • Mild Cognitive Impairment (MCI)
  • Virtual Reality
  • Eye Movement Disorder
  • Multimodal Monitoring
  • Older Adults
04

Who can participate

The criteria were revised on the registry on Nov 13, 2026. See what changed

Ages eligible
30 Years to 85 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population will include healthy young adults aged 30-39 years, as well as cognitively healthy older adults and individuals with mild cognitive impairment (MCI) aged 65-85 years.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. A score of 23 or higher on the .
  2. A Clinical Dementia Rating score of 0 for cognitively healthy participants or 0.5 for participants with mild cognitive impairment (MCI).
  3. Age between 30 and 39 years for healthy young adults, or between 65 and 85 years for cognitively healthy older adults and participants with MCI.
  4. Right-hand dominance.
  5. Adequate visual function to complete virtual reality (VR) and eye-tracking tasks, defined as corrected binocular visual acuity of at least 0.5 without severe visual field deficits.

Exclusion criteria

Exclusion Criteria:

  1. Presence or history of major psychiatric disorders or central nervous system diseases.
  2. Significant ocular diseases, such as untreated cataracts, active retinal diseases, moderate-to-severe or poorly controlled glaucoma, or marked visual field deficits beyond a specified level.
  3. Epilepsy.
  4. Severe dizziness or VR-induced motion sickness.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
192 participants (estimated)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • Young Adults

    Healthy young adults (aged 30-39 years) with no history of neurological or psychiatric disorders. Participants will complete standardized virtual reality (VR) driving tasks with integrated eye-tracking and upper-limb motion recording to establish normative visuomotor and cognitive performance benchmarks.

  • Cognitively Healthy Older Adults

    Community-dwelling older adults (≥65 years) with normal cognitive function based on standardized screening (e.g., MoCA within normal range). Participants will undergo the same VR-based assessments to examine age-related changes in visual attention, executive control, and visuomotor coupling.

  • Mild Cognitive Impairment (MCI)

    Older adults clinically identified with mild cognitive impairment according to established diagnostic criteria. Participants will complete identical VR driving tasks to investigate alterations in visual search behavior, attentional control, and visuomotor integration, and to support development of predictive AI models for cognitive decline and driving risk.

06

What researchers measure

Primary outcomes

  1. Time to First Fixation (TFF) within the Area of Interest

    Time to First Fixation (TFF) is defined as the time interval from event onset (t₀) to the participant's first fixation within the predefined Area of Interest (AOI). A shorter TFF indicates faster attentional orienting. Units of Measure: milliseconds (ms) for each predefined AOI/event condition.

    Time frame: Baseline

Secondary outcomes

  1. Number of Fixations on the Area of Interest

    Number of Fixations is defined as the total count of fixations within the predefined Area of Interest (AOI) during task performance. A higher number of fixations indicates greater visual search activity toward target stimuli. Unit of Measure: count.

    Time frame: Baseline

  2. Total Fixation Duration (TFD) on the Area of Interest

    Total Fixation Duration (TFD) is defined as the cumulative fixation time within the predefined Area of Interest (AOI) during the task. Longer fixation duration indicates greater attentional engagement with the target stimulus. Unit of measure: Milliseconds.

    Time frame: Baseline

  3. Steering Reaction Time

    Steering Reaction Time is defined as the interval from event onset (t₀) to the initial steering wheel deviation of ≥5°. This measure reflects motor initiation speed during driving tasks. Steering Reaction Time will be calculated separately for each driving scenario or curve type. Unit of Measure: Milliseconds (ms).

    Time frame: Baseline

  4. Steering Reversal Rate (SRR)

    Steering Reversal Rate (SRR) is defined as the number of steering direction changes per minute during curve driving, using a steering-wheel angle threshold of 0.5°. Higher SRR values indicate increased steering corrections and may reflect reduced motor control stability and increased driving workload. Unit of Measure: Reversals/minute.

    Time frame: Baseline

  5. Speed Change During Driving Tasks

    Speed Change is defined as the difference in average vehicle speed before and after event onset during driving tasks. This measure reflects adaptive driving behavior in response to traffic events or environmental changes, with larger changes indicating greater speed adjustment. Speed Change will be calculated separately for each driving condition. Unit of Measure: Kilometers per hour (km/h).

    Time frame: Baseline

  6. Reaction Time in Speed-Limit Judgment Tasks

    Reaction Time in Speed-Limit Judgment Tasks is defined as the elapsed time between the presentation of a speed-limit stimulus and the participant's response. This measure assesses the speed of driving-related decision-making under varying cognitive demands, with longer reaction times indicating greater cognitive processing demands. Reaction time will be calculated for each task condition. Unit of Measure: Milliseconds (ms).

    Time frame: Baseline

  7. Accuracy in Speed-Limit Judgment Tasks

    Accuracy in Speed-Limit Judgment Tasks is defined as the percentage of correct responses to speed-limit judgment tasks performed during driving. This measure assesses cognitive performance under dual-task conditions, with higher accuracy indicating better task performance and cognitive processing. Accuracy will be calculated for each task condition. Unit of Measure: Percentage (%).

    Time frame: Baseline

  8. Standard Deviation of Lane Position (SDLP)

    Standard Deviation of Lane Position (SDLP) is defined as the variability of the vehicle's lateral lane position during driving tasks. SDLP reflects lane-keeping ability and driving stability under different driving conditions. The lower SDLP mean better driving stability. Unit of Measure: Meters (m).

    Time frame: Baseline

  9. Frequency of Driving Errors

    Driving Errors are defined as the number of adverse driving events occurring during the driving task, including lane departures, collisions, and incorrect responses to secondary tasks. This measure reflects overall driving performance and safety. Error frequencies will be calculated for each driving condition, and error types will be analyzed separately. Unit of Measure: Count.

    Time frame: Baseline

  10. Montreal Cognitive Assessment (MoCA) Score

    The MoCA is used to assess global cognitive function. Participants complete a standardized set of tasks covering attention, memory, language, visuospatial abilities, and executive functions. The total MoCA score reflects overall cognitive performance.Unit of Measure: Points (0-30).

    Time frame: Baseline

  11. Digit Span Test Score

    The Digit Span Test evaluates working memory capacity by requiring participants to recall sequences of numbers in forward and backward order. The highest correctly recalled sequence length is recorded separately for forward and backward trials. Unit of Measure: Number of digits correctly recalled.

    Time frame: baseline

  12. Knox Cube Test-Revised Score

    The Knox Cube Test-Revised assesses visuospatial sequential memory. Participants must replicate sequences of cube taps demonstrated by the examiner. The total number of correctly recalled sequences reflects visuospatial memory performance. Unit of Measure: Number of sequences correctly recalled.

    Time frame: baseline

  13. Conners Continuous Performance Test 3 (CPT 3) Metrics

    The Conners CPT 3 assesses sustained attention and inhibitory control. Primary metrics include reaction time, omission errors, commission errors, and detectability (d'). Each metric will be reported separately for each test condition. Unit of Measure: Reaction Time: milliseconds (ms); Omission Errors: count; Commission Errors: count; and Detectability (d'): unitless index.

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Dec 2029, 42 months after the start.

Of 506 non-industry observational studies under Cognitive Dysfunction, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 118. This study's planned 42 months is below that.

Counting every sponsor, half of 545 studies reached it within 48 months; a quarter within 21 and three quarters within 118.

How these figures are worked out, and which studies are left out of them.

Registered
May 19, 2026
First posted
Jun 18, 2026
StartActual
Jun 20, 2026
Primary completionEst.
Dec 31, 2029
CompletionEst.
Dec 31, 2029
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 13, 2026
Sites
National Cheng-Kung University Hospital is now Recruiting
Nov 13, 2026
Eligibility
5 inclusion criteria added, 1 removed; 1 exclusion criterion edited, 3 added
What changed in the criteria
Inclusion criteria
  • Removed(1) a score of 23 or higher on the Montreal Cognitive Assessment; (2) a Clinical Dementia Rating score of 0 for cognitively healthy participants or 0.5 for participants with mild cognitive impairment (MCI); (3) healthy young adults aged between 30 and 39 years, and cognitively healthy older adults and participants with MCI aged between 65 and 85 years; (4) right-hand dominance; and (5) adequate visual function to complete VR and eye-tracking tasks, defined as corrected binocular visual acuity of at least 0.5 without severe visual field deficits.
  • AddedA score of 23 or higher on the Montreal Cognitive Assessment.
  • AddedA Clinical Dementia Rating score of 0 for cognitively healthy participants or 0.5 for participants with mild cognitive impairment (MCI).
  • AddedAge between 30 and 39 years for healthy young adults, or between 65 and 85 years for cognitively healthy older adults and participants with MCI.
  • AddedRight-hand dominance.
  • AddedAdequate visual function to complete virtual reality (VR) and eye-tracking tasks, defined as corrected binocular visual acuity of at least 0.5 without severe visual field deficits.
Exclusion criteria
  • AddedPresence or history of major psychiatric disorders or central nervous system diseases.
  • Edited(1) the presence or history of major psychiatric disorders or central nervous system diseases; (2) significantSignificant ocular diseases, such as untreated cataracts, active retinal diseases, moderate-to-severe or poorly controlled glaucoma, or marked visual field deficits beyond a specified level; (3) epilepsy; and (4) severe dizziness or VR-induced motion sickness.
  • AddedEpilepsy.
  • AddedSevere dizziness or VR-induced motion sickness.
Nov 13, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • National Cheng-Kung University Hospital · Tainan, TaiwanContact added h•••@mail.ncku.edu.tw · •••3535
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Not yet recruiting→Recruiting
    National Cheng-Kung University Hospital is now Recruiting
    Eligibility 5 inclusion criteria added, 1 removed; 1 exclusion criterion edited, 3 added
    What changed in the criteria
    Inclusion criteria
    • Removed(1) a score of 23 or higher on the Montreal Cognitive Assessment; (2) a Clinical Dementia Rating score of 0 for cognitively healthy participants or 0.5 for participants with mild cognitive impairment (MCI); (3) healthy young adults aged between 30 and 39 years, and cognitively healthy older adults and participants with MCI aged between 65 and 85 years; (4) right-hand dominance; and (5) adequate visual function to complete VR and eye-tracking tasks, defined as corrected binocular visual acuity of at least 0.5 without severe visual field deficits.
    • AddedA score of 23 or higher on the Montreal Cognitive Assessment.
    • AddedA Clinical Dementia Rating score of 0 for cognitively healthy participants or 0.5 for participants with mild cognitive impairment (MCI).
    • AddedAge between 30 and 39 years for healthy young adults, or between 65 and 85 years for cognitively healthy older adults and participants with MCI.
    • AddedRight-hand dominance.
    • AddedAdequate visual function to complete virtual reality (VR) and eye-tracking tasks, defined as corrected binocular visual acuity of at least 0.5 without severe visual field deficits.
    Exclusion criteria
    • AddedPresence or history of major psychiatric disorders or central nervous system diseases.
    • Edited(1) the presence or history of major psychiatric disorders or central nervous system diseases; (2) significantSignificant ocular diseases, such as untreated cataracts, active retinal diseases, moderate-to-severe or poorly controlled glaucoma, or marked visual field deficits beyond a specified level; (3) epilepsy; and (4) severe dizziness or VR-induced motion sickness.
    • AddedEpilepsy.
    • AddedSevere dizziness or VR-induced motion sickness.
    Site contacts Changed at 1 site. See the sites
    Show the site
    • National Cheng-Kung University Hospital · Tainan, TaiwanContact added h•••@mail.ncku.edu.tw · •••3535
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07656389
Responsible party
Sponsor
First posted
Jun 18, 2026
Start date
Jun 20, 2026
Primary completion
Dec 31, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Nov 13, 2026

Study contacts

Hsiu-Yun Hsu, Ph.D
Contact
hyhsu@mail.ncku.edu.tw
886-6-2353535 ext. 2669

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion